Treatment options for rheumatoid arthritis

被引:0
|
作者
Kavanaugh, AF
机构
来源
AMERICAN JOURNAL OF MANAGED CARE | 1999年 / 5卷 / 14期
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Over the last several decades, approaches to the management of rheumatoid arthritis (RA) have been empirical. Subsets of RA patients respond well to traditional disease-modifying antirheumatic drugs (DMARDs), either as single therapy or in combination. However, a significant population remains untreated or undertreated. The lessons learned from DMARD strategies have led to stratification of patients based on observed or expected disease progression. At the same time, clinicians have gained a better understanding of the immunology and immunopathophysiology of RA. The advent of monoclonal antibody technology and other advances in biotechnology have resulted in the development of agents that target specific components of the immune response. Recent trials with 2 antitumor necrosis factor alpha (TNF alpha) chimeric antibody agents, etanercept and infliximab, have shown promising results, both as proof of concept and in more rigorous clinical trial populations leg, patients who are refractory to (DMARDs). Future directions include combination DMARD/biologic agent therapy, and other molecular strategies targeted to parts of the immune response that appear to be dysregulated in RA patients. Stratifying patients will hopefully lead to more tailored and targeted therapies and a more cost-effective approach to RA management.
引用
收藏
页码:S845 / S851
页数:7
相关论文
共 50 条
  • [31] Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis
    Yoon-Kyoung Sung
    Soo-Kyung Cho
    Dam Kim
    Chan-Bum Choi
    Soyoung Won
    So-Young Bang
    Hoon-Suk Cha
    Jung-Yoon Choe
    Won Tae Chung
    Seung-Jae Hong
    Jae-Bum Jun
    Hyoun Ah Kim
    Jinseok Kim
    Seong-Kyu Kim
    Tae-Hwan Kim
    Hye-Soon Lee
    Jaejoon Lee
    Jisoo Lee
    Shin-Seok Lee
    Sung Won Lee
    Yeon-Ah Lee
    Seong-Su Nah
    Chang-Hee Suh
    Dae-Hyun Yoo
    Bo Young Yoon
    Sang Cheol Bae
    Rheumatology International, 2017, 37 : 975 - 982
  • [32] A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis
    Choi, HK
    Seeger, JD
    Kuntz, KM
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (06) : 1156 - 1165
  • [33] SERUM IMMUNOGLOBULINS LEVEL IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS ON DIFFERENT TREATMENT OPTIONS
    Mogosan, C.
    Marin, E. M.
    Popescu, C.
    Enache, L.
    Dumitrescu, B.
    Agache, M.
    Dinache, O. G.
    Ionescu, C. E.
    Minca, D.
    Codreanu, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1235 - 1235
  • [34] Factors that are important to patients with rheumatoid arthritis and their physicians when considering treatment options
    Lisicki, Robert
    Chu, Lida
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S862 - S863
  • [35] Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis
    Sung, Yoon-Kyoung
    Cho, Soo-Kyung
    Kim, Dam
    Choi, Chan-Bum
    Won, Soyoung
    Bang, So-Young
    Cha, Hoon-Suk
    Choe, Jung-Yoon
    Chung, Won Tae
    Hong, Seung-Jae
    Jun, Jae-Bum
    Kim, Hyoun Ah
    Kim, Jinseok
    Kim, Seong-Kyu
    Kim, Tae-Hwan
    Lee, Hye-Soon
    Lee, Jaejoon
    Lee, Jisoo
    Lee, Shin-Seok
    Lee, Sung Won
    Lee, Yeon-Ah
    Nah, Seong-Su
    Suh, Chang-Hee
    Yoo, Dae-Hyun
    Yoon, Bo Young
    Bae, Sang Cheol
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (06) : 975 - 982
  • [36] The knee joint in rheumatoid arthritis-current orthopaedic surgical treatment options
    Maderbacher, G.
    Greimel, F.
    Schaumburger, J.
    Grifka, J.
    Baier, C.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2018, 77 (10): : 882 - 888
  • [37] Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options
    Dejcman, Daniel
    Skowasch, Dirk
    Pizarro, Carmen
    Krause, Andreas
    Thomas, Daniel
    Schafer, Valentin Sebastian
    CURRENT RHEUMATOLOGY REVIEWS, 2021, 17 (01) : 17 - 28
  • [38] REFRACTORY RHEUMATOID-ARTHRITIS - THERAPEUTIC OPTIONS
    CASH, JM
    WILDER, RL
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1995, 21 (01) : 1 - 18
  • [39] Imaging in rheumatoid arthritis: options, uses and optimization
    Grassi, Walter
    Okano, Tadashi
    Di Geso, Luca
    Filippucci, Emilio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (10) : 1131 - 1146
  • [40] RHEUMATOID ARTHRITIS DEBATE Current treatment of rheumatoid arthritis
    Gough, Andrew K.
    Foo, Joanne
    BRITISH MEDICAL JOURNAL, 2011, 343